top of page

Pipeline

​

Dawah Pharmaceuticals Inc. is advancing global healthcare through a robust pipeline of essential drugs in collaboration with top-tier international Contract Manufacturing Organizations (CMOs). By leveraging strategic overseas partnerships, we ensure the efficient delivery of FDA-compliant drugs that address critical therapeutic needs across a wide range of disease states.

​

Therapeutic Classifications and Disease States
​
Sterile Injectables
  • Antipsychotics: Supporting chronic and acute mental health conditions.

  • Paralytics: Facilitating anesthesia and patient stabilization in surgical and critical care settings.

  • Antibiotics: Combating severe bacterial infections, including resistant strains.

  • Oncology Drugs: Addressing various cancers with innovative and life-saving treatments.

  • Antifungals: Treating systemic and invasive fungal infections.

​

Ophthalmics
  • Anti-inflammatory Agents: Reducing inflammation in ocular diseases.

  • Antibiotic-Corticosteroid Combinations: Treating bacterial infections with concurrent inflammation.

  • Antihistamines: Providing relief from allergic conjunctivitis and related ocular allergies.

​

IV Bags and Total Parenteral Nutrition (TPN)
  • Pain Management: Offering intravenous acetaminophen for effective pain and fever control.

  • Critical Care Solutions: Including dopamine and electrolytes for emergency and intensive care applications.

  • Nutritional Support: High-use TPN formulations for patients with impaired oral intake.

​

Overseas Partnerships

Dawah Pharmaceuticals has meticulously evaluated over 30 global CMOs and strategically partnered with two industry leaders based overseas. These partnerships are integral to our operations, allowing us to:

  • Optimize manufacturing costs with contributions of the sterile production cost by our selected CMOs.

  • Expedite the production and regulatory approval processes for our pipeline drugs.

​

Key Activities Provided by CMOs
  1. Comprehensive Development: Formulation, process design, and analytical testing.

  2. Regulatory Preparedness: Manufacturing registration batches and compiling FDA dossiers.

  3. Stability Testing: Ensuring efficacy and safety over extended periods.

​

Commitment to Excellence

Our partnerships empower Dawah Pharmaceuticals to maintain agility while delivering high-quality, FDA-compliant drugs to address critical healthcare needs. By continuously assessing market trends and patient requirements, we are committed to expanding our pipeline and improving global access to essential medications.

bottom of page